KLRC1 and neoplasm: Mice were injected with 104 BCL1 cells i.v. followed by antimouse NKG2A or isotype control i.v. on days 6 and 13, and antimouse CD20 i.p. or isotype control on day 7 post-tumour injection (Fig. 6e).